Published in Drug Week, February 6th, 2004
More than 3000 patients were enrolled in these double-blind, randomized, vehicle-controlled studies, which were conducted in more than 100 centers around the U.S. and Canada.
"We are pleased to announce the successful completion of the largest clinical studies ever undertaken by this company," said Steve Garrett, senior vice president of clinical research. "The databases have been locked, and preliminary data analyses are complete. We will be working...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.